Key facts
- Patient Discovery’s last known valuation is $22.0M (Feb 2025).
- It has raised $8.3M; the latest was Later Stage VC ($2.0M) in Feb 2025.
- Notable investors include CS Venture Opportunities Fund, Hard Yaka.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Patient Discovery
- ·The full record, as it builds
Funding rounds
No funding rounds for Patient Discovery are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Patient Discovery
Developer of an artificial intelligence-based patient well-being platform intended to transform how all patients are understood, supported, and treated. The company's platform offers dynamic connections to personalized services, education, and support, increased appointment productivity and health equity across patient populations, enabling patients to organize their thoughts before their medical appointments to facilitate conversations with their healthcare teams.
- Sector
- Healthcare
- HQ
- Newton, MA, United States
- Founded
- 2016
- Employees
- 18
- Website
- patientdiscovery.com/
- Ownership
- Privately Held (backing)
Patient Discovery doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Patient Discovery shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Patient Discovery in its N-PORT filings yet. We sweep new filings monthly.